Literature DB >> 11536372

Elevated furin expression in aggressive human head and neck tumors and tumor cell lines.

D E Bassi1, H Mahloogi, L Al-Saleem, R Lopez De Cicco, J A Ridge, A J Klein-Szanto.   

Abstract

Pro-protein convertases (PCs) are proteases that recognize and cleave precursor proteins. Furin, a well-studied PC, is ubiquitously expressed, and it has been implicated in many physiological and pathological processes. Some substrates for furin, such as membrane type 1 (MT1) matrix metalloproteinase (MMP), an MMP that activates gelatinase, a collagen-degrading enzyme, are associated with the advanced malignant phenotype. This report examines the expression of furin in carcinoma cell lines of different invasive ability. The levels of furin mRNA and protein correlated with the aggressiveness of tumor cell lines derived from head and neck and lung cancers. Furin expression also was investigated in primary head and neck squamous cell carcinomas (HNSCCs). Furin mRNA was not detected in nonmetastasizing carcinomas. In contrast, furin mRNA was expressed in metastasizing HNSCCs. Immunohistochemistry and Western blot analysis confirmed these results at the protein level. Furin activity was investigated indirectly by evaluating the expression of the pro-form and the processed form of MT1-MMP. Metastasizing HNSCCs showed increased expression of MT1-MMP. Furthermore, pro-MT1-MMP expression was noted in most of the nonmetastasizing HNSCCs analyzed by Western blot, and it was absent in the metastasizing HNSCCs. This finding suggests a lower level of furin-mediated MT1-MMP activation in the less aggressive cancers. These observations indicate that furin plays a role in tumor progression. Its overexpression in more aggressive or metastasizing cancers resulted in increased MMP processing. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11536372     DOI: 10.1002/mc.1057

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  65 in total

1.  Molecular Validation of PACE4 as a Target in Prostate Cancer.

Authors:  François D'Anjou; Sophie Routhier; Jean-Pierre Perreault; Alain Latil; David Bonnel; Isabelle Fournier; Michel Salzet; Robert Day
Journal:  Transl Oncol       Date:  2011-06-01       Impact factor: 4.243

Review 2.  Furin at the cutting edge: from protein traffic to embryogenesis and disease.

Authors:  Gary Thomas
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

3.  On the cutting edge of proprotein convertase pharmacology: from molecular concepts to clinical applications.

Authors:  Frédéric Couture; François D'Anjou; Robert Day
Journal:  Biomol Concepts       Date:  2011-10-01

4.  Association of FURIN and ZPR1 polymorphisms with metabolic syndrome.

Authors:  Chikara Ueyama; Hideki Horibe; Yuichiro Yamase; Tetsuo Fujimaki; Mitsutoshi Oguri; Kimihiko Kato; Masazumi Arai; Sachiro Watanabe; Toyoaki Murohara; Yoshiji Yamada
Journal:  Biomed Rep       Date:  2015-06-29

Review 5.  Processing of peptide and hormone precursors at the dibasic cleavage sites.

Authors:  Mohamed Rholam; Christine Fahy
Journal:  Cell Mol Life Sci       Date:  2009-03-20       Impact factor: 9.261

Review 6.  Melanotrope cells as a model to understand the (patho)physiological regulation of hormone secretion.

Authors:  R Vàzquez-Martínez; J R Peinado; D Cruz-García; A Ruiz-Navarro; F Gracia-Navarro; Y Anouar; M C Tonon; H Vaudry; J P Castaño; M M Malagón
Journal:  J Endocrinol Invest       Date:  2005-11       Impact factor: 4.256

7.  Functional consequences of the subdomain organization of the sulfs.

Authors:  Renhong Tang; Steven D Rosen
Journal:  J Biol Chem       Date:  2009-06-11       Impact factor: 5.157

8.  Regulation of HIF-1 alpha by the proprotein convertases furin and PC7 in human squamous carcinoma cells.

Authors:  Jian Fu; Jirong Zhang; Yulan Gong; Courtney Lyons Testa; Andres J Klein-Szanto
Journal:  Mol Carcinog       Date:  2014-01-16       Impact factor: 4.784

Review 9.  Role of subtilisin-like convertases in cadherin processing or the conundrum to stall cadherin function by convertase inhibitors in cancer therapy.

Authors:  E J Müller; R Caldelari; H Posthaus
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

10.  A femtomol range FRET biosensor reports exceedingly low levels of cell surface furin: implications for the processing of anthrax protective antigen.

Authors:  Katarzyna Gawlik; Albert G Remacle; Sergey A Shiryaev; Vladislav S Golubkov; Mingxing Ouyang; Yingxiao Wang; Alex Y Strongin
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.